Modulation of intracellular copper levels as the mechanism of action of anticancer copper complexes: Clinical relevance
Copper (Cu) is a vital element required for cellular growth and development; however, even
slight changes in its homeostasis might lead to severe toxicity and deleterious medical …
slight changes in its homeostasis might lead to severe toxicity and deleterious medical …
Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders
SM Stanford, N Bottini - Nature Reviews Drug Discovery, 2023 - nature.com
Protein phosphatases act as key regulators of multiple important cellular processes and are
attractive therapeutic targets for various diseases. Although extensive effort has been …
attractive therapeutic targets for various diseases. Although extensive effort has been …
Genomics and evolution of protein phosphatases
Protein phosphatases are the essential opposite to protein kinases; together, these enzymes
regulate all protein phosphorylation and most cellular processes. To better understand the …
regulate all protein phosphorylation and most cellular processes. To better understand the …
[HTML][HTML] Chemical probes and drug leads from advances in synthetic planning and methodology
CJ Gerry, SL Schreiber - Nature Reviews Drug Discovery, 2018 - nature.com
Screening of small-molecule libraries is a productive method for identifying both chemical
probes of disease-related targets and potential starting points for drug discovery. In this …
probes of disease-related targets and potential starting points for drug discovery. In this …
Protein tyrosine phosphatases as potential therapeutic targets
Protein tyrosine phosphorylation is a key regulatory process in virtually all aspects of cellular
functions. Dysregulation of protein tyrosine phosphorylation is a major cause of human …
functions. Dysregulation of protein tyrosine phosphorylation is a major cause of human …
The JAK/STAT pathway in obesity and diabetes
EN Gurzov, WJ Stanley, EG Pappas… - The FEBS …, 2016 - Wiley Online Library
Diabetes mellitus are complex, multi‐organ metabolic pathologies characterized by
hyperglycemia. Emerging evidence shows that the highly conserved and potent JAK/STAT …
hyperglycemia. Emerging evidence shows that the highly conserved and potent JAK/STAT …
Targeting the disordered C terminus of PTP1B with an allosteric inhibitor
PTP1B, a validated therapeutic target for diabetes and obesity, has a critical positive role in
HER2 signaling in breast tumorigenesis. Efforts to develop therapeutic inhibitors of PTP1B …
HER2 signaling in breast tumorigenesis. Efforts to develop therapeutic inhibitors of PTP1B …
Drugging undruggable molecular cancer targets
JS Lazo, ER Sharlow - Annual review of pharmacology and …, 2016 - annualreviews.org
Cancer, more than any other human disease, now has a surfeit of potential molecular targets
poised for therapeutic exploitation. Currently, a number of attractive and validated cancer …
poised for therapeutic exploitation. Currently, a number of attractive and validated cancer …
Targeting tyrosine phosphatases: time to end the stigma
SM Stanford, N Bottini - Trends in Pharmacological Sciences, 2017 - cell.com
Protein tyrosine phosphatases (PTPs) are a family of enzymes essential for numerous
cellular processes, and several PTPs have been validated as therapeutic targets for human …
cellular processes, and several PTPs have been validated as therapeutic targets for human …
Recent advance on PTP1B inhibitors and their biomedical applications
Abstract Protein Tyrosine Phosphatase 1B (PTP1B), as one of the most important members
in PTP superfamily, plays a vital role in conducting various cellular functions. So far, PTP1B …
in PTP superfamily, plays a vital role in conducting various cellular functions. So far, PTP1B …